Eleven of them had developed aspergillosis (STAT3-asp: six with chronic pulmonary aspergillosis (CPA), three allergic bronchopulmonary aspergillosis (ABPA), and two had both ABPA-CPA; eight were with ongoing aspergillosis and three in complete remission at the time of our study). This evidence concerns the gene STAT3 and aspergillosis.